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Abstract
An effective host response against viral infection of the central ner-
vous system (CNS) is the principal factor dictating the outcome of
infection. It is the responsibility of the immune response to contain
and control viral replication. Paradoxically, it is the immune response
that may also contribute to the development of neuropathology. We
have used mouse hepatitis virus (MHV), a positive-strand RNA virus,
infection of the CNS to understand the dynamic interaction between
viral replication, protection, and pathology with an emphasis on
understanding how chemokines participate in these interrelated
processes. Herein, we demonstrate the complexity of the chemokine
response to MHV infection of the CNS and the delicate balance that
exists between host defense and development of disease.
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Introduction
Viral infection of the central nervous system
(CNS) presents unique problems in how the
host is able to encounter, recognize, and elim-
inate foreign antigen. Contributing factors
include anatomic difficulties imposed by the
blood-brain-barrier as well as the absence of
evident lymphatic drainage. Furthermore, the
relative absence of MHC class I and II expres-
sion combined with limited numbers of anti-
gen presenting cells suggest that mounting an
effective immune response against a viral anti-
gen is difficult. However, in spite of these
apparent obstacles, activated cells of the
immune system are able to enter the CNS and
participate in elimination of viral antigen.
Moreover, the presence of activated immune
cells e.g., T lymphocytes and macrophages
contribute to the development of pathology in
various viral model systems.
The molecular mechanisms governing the
development of inflammatory events and an
adaptive immune response to viral infection
of the CNS are just now being understood
(1–3). Increasing evidence has demonstrated
the importance of chemokines in orchestrat-
ing events surrounding inflammation follow-
ing viral infection or injury. Chemokines rep-
resent an ever-growing family of secreted pro-
teins that function as potent mediators of
inflammation (4). The chemokine superfam-
ily is divided into four subfamilies based on
both structural and functional criteria. The two
major subfamilies are the CXC and CC
chemokines. The CXC subfamily is struc-
turally characterized by conserved cysteine
residues that are separated by an amino-acid
whereas the CC subfamily has the conserved
cysteine residues adjacent to one another. Lym-
photactin, the sole member of the C family, is
chemotactic for T lymphocytes. The CX3C
chemokine, fractalkine, is unique in that it is
expressed on the surface of cells as well as
being secreted into the surrounding environ-
ment. Chemokines target distinct leukocyte
populations during periods of inflammation
through interaction with specific receptors.
The CXC chemokines function primarily in
attracting neutrophils, yet have a limited effect
on T lymphocytes and monocytes. However,
there are exceptions to this rule in that CXC
chemokines that lack the glutamic acid-
leucine-arginine (ELR) motif on the amino
terminus are chemotactic for T cells by bind-
ing to the shared receptor CXCR3. The CC
chemokines attract T lymphocytes, mono-
cytes, and macrophages but not neutrophils.
To date, all chemokine receptors identified are
members of the seven-transmembrane G pro-
tein-coupled receptor superfamily (5). Fol-
lowing chemokine binding to its cognate
receptor, signaling events are initiated that
result in various cellular processes such as
increases in intracellular calcium, production
of cytokines and chemokines, adhesion to the
endothelial matrix, and chemotaxis (6). In
addition, there is growing evidence that
chemokine receptors influence the polariza-
tion of T cell immune response (i.e., Th1 vs.
Th2) in tissue (7).
Viral infection of the CNS results in a tem-
poral expression of chemokines by resident
cells of the CNS e.g., astrocytes and microglia
as well as by inflammatory cells. Recent stud-
ies have demonstrated a relationship between
chemokine expression and leukocyte entry into
the CNS following viral infection (8–11).
There is an increasing amount of evidence indi-
cating that chemokine expression is beneficial
by attracting lymphocytes that participate in
an antiviral response. Conversely, chronic
chemokine expression in response to persis-
tent viral infection of the CNS may contribute
to neuropathology by attracting activated
T lymphocytes and macrophages into the CNS
which then release cytotoxic factors. This brief
review will focus on recent studies evaluating
the functional significance of chemokine
expression as it relates to both host defense
and disease development following mouse
hepatitis virus (MHV) infection of the CNS.
MHV Infection and Neurologic Disease
MHV is a positive-strand RNA virus that is
a member of the Coronaviridae family (12).
Intracranial infection of susceptible strains of
mice with MHV results in an acute encepha-
lomyelitis characterized by viral replication
in glia and neurons accompanied by leukocyte
infiltration into the CNS. A robust cell-medi-
ated immune response is essential in control
of viral replication. Increased mortality and
enhanced recovery of virus from the CNS has
been reported in mice lacking functional CD4+
or CD8+ lymphocytes (1,13–15). Adoptive
transfer of MHV-specific T cell clones medi-
ates protection from disease and clearance of
MHV from the CNS (16,17). Moreover, MHV
infection of IFN-γ –/– mice results in increased
disease severity accompanied by a diminished
ability to control viral replication within the
brain (18,19). Collectively, these data indicate
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that a Th1 response characterized by the accu-
mulation of both CD4+ and CD8+ T lympho-
cytes and expression of IFN-γ is required for
protection from neurologic disease and clear-
ance of MHV.
MHV infection of the CNS results in a com-
plex, well-orchestrated expression of
chemokine genes which appears to be dictated,
in part, by viral burden (8). IP-10 mRNA tran-
scripts are detected early (day 1 postinfection
p.i.) and colocalize with areas of MHV repli-
cation. By day 6 p.i., virus has spread through-
out the parenchyma and chemokine transcripts
detected at this time include IP-10, RANTES,
Mig, MCP-1, MCP-3, MIP-1α, MIP-1β, and
RANTES. Analysis of chemokine receptor
mRNA expression indicates CXCR3, CCR1,
CCR2,and CCR5 are predominantly expressed
during acute disease (M.T.L. and T.E.L.,
unpublished observations). Double-labeling
revealed that astrocytes and microglia
expressed mRNA transcripts for IP-10 and Mig
during the acute stage of disease (3,8).
Macrophage/microglial cells (determined by
F4/80 antigen expression) were determined to
express the chemokine receptor CCR5 whereas
both CD4+ and CD8+ T lymphocytes expressed
CXCR3 (M.T.L. and T.E.L., unpublished
observations; 2).
By day 12 p.i., mice clear virus below levels
of detection (as determined by plaque assay),
however, viral RNA and antigen persists within
white matter tracts. Persistent infection of mice
with MHV results in demyelination in the
majority of mice characterized clinically by
partial-to-complete hind-limb paralysis and
histologically by T lymphocyte and macro-
phage accumulation at sites of myelin destruc-
tion (1,14,15,20–23). Due to the similarities
in both clinical and histologic disease between
MHV-induced demyelination and the human
demyelinating disease multiple sclerosis (MS),
the MHV system is considered to be an excel-
lent model in which to study the underlying
immunopathological mechanisms contribut-
ing to demyelination in MS patients (14,19).
Similar to MS, components of the immune
system e.g., T lymphocytes and macrophages
are considered important in contributing to the
development of demyelination (1,15,22,23).
In situ hybridization analysis revealed that
IP-10 and RANTES are predominantly
expressed surrounding demyelinating lesions
present in the spinal cords of mice persistently
infected with MHV (1,8). In addition, astro-
cytes were determined to be the cellular source
of IP-10 at this stage of disease whereas inflam-
matory cells expressed RANTES (1,8).
The focus of our research is aimed at char-
acterizing the role of chemokines in CNS host
defense as well as immune-mediated demyeli-
nation utilizing the MHV model of viral-
induced CNS disease. As stated earlier, CD4+
and CD8+ T lymphocytes contribute to an
antiviral response during the acute stage of
disease. The majority of T lymphocytes
which infiltrate into the CNS expressed the
chemokine receptor CXCR3 (2,3). This sug-
gests that the ligands for CXCR3, IP-10 and
Mig, may perform prominent roles in host
defense through attraction of T lymphocytes
into the CNS following viral infection. How-
ever, although T lymphocytes are essential in
host defense, CD4+ T lymphocytes have also
been shown to participate in MHV induced
demyelination during the chronic stage of
infection (1). As mentioned earlier, IP-10 and
RANTES are prominently expressed sur-
rounding demyelinating lesions suggesting
that chronic expression of these molecules may
participate in MHV induced demyelination
through attraction of inflammatory CD4+
T lymphocytes and macrophages into the CNS
(1,8). Herein, we present data focused on defin-
ing the functional significance of IP-10, Mig,
and RANTES expression as it relates to both
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host defense and neuropathology following
MHV infection of the CNS.
Chemokines and CNS Host Defense
IP-10 and Mig are non-ELR (glutamic acid-
leucine-arginine) CXC chemokines that exert
a chemotactic effect on T lymphocytes through
interaction with the receptor CXCR3 (24–27).
IP-10 expression is inducible by both IFN-α/β
and IFN-γ while Mig expression is strictly
dependent upon IFN-γ (26). Analysis of the
kinetics of IP-10 and Mig mRNA expression
within the CNS of MHV-infected mice
revealed that IP-10 is clearly detectable by day
2 p.i. and is prominently expressed at days 7,
12 and 35 p.i. (8). In contrast, Mig expression
is limited to days 7 through 12 p.i. which coin-
cides with the presence of IFN-γ mRNA tran-
scripts (3). Based upon these data, it is
interesting to speculate that early expression
of IP-10 may reflect local production of IFN-
α/β in response to MHV infection which in
turn activates both infected and uninfected
cells to produce IP-10. On the other hand, Mig
expression is delayed until activated T lym-
phocytes enter the CNS and produce IFN-γ.
In order to characterize the functional sig-
nificance of IP-10 and Mig expression fol-
lowing MHV infection of the CNS, rabbit
antisera specific for either IP-10 or Mig was
administered to infected mice. Neutralization
of either IP-10 or Mig activity resulted in a
dramatic increase in mortality when compared
to control mice treated with normal rabbit
serum (NRS) (2,3) (Fig. 1). Surviving mice
treated with either anti-IP-10 or anti-Mig dis-
played significantly higher titers of virus as
compared to titers present in NRS-treated mice
indicating that neutralization of either IP-10
or Mig activity during acute disease results in
increased mortality that correlated with an
increase in viral burden within the CNS (2,3)
(Table 1).
As previously mentioned, CD4+ and CD8+
T lymphocytes present within the CNS of
MHV infected mice express CXCR3, the
shared receptor for Mig and IP-10 (2). This
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Fig. 1. Increased mortality in MHV-infected mice
treated with either anti-IP-10 or anti-Mig. Mice were
intracranially infected with 10 pfu of MHV and treated
intraperitoneally with either anti-IP-10, anti-Mig or
NRS at days 0, 2, 5, 7 and 9 p.i. By 12 d p.i., approx
50% of NRS treated mice survived the infection
whereas less than 10% of anti-IP-10 and anti-Mig
treated mice survived.
Table 1. CNS viral titer following antisera treatment
Treatment days Post infection n Log10 PFU/g
anti-IP-10 17 4 5.9 ± 0.1a0
10 4 5.7 ± 0.3b0
anti-Mig 17 4 5.9 ± 0.04b
10 4 5.4 ± 0.3b0
NRS 17 4 5.0 ± 0.07b
10 4 2.1 ± 0.20b
aData presented as mean ± SEM
bp<0.001 when compared to NRS treated mice
suggested that both IP-10 and Mig are able to
attract T lymphocytes into the CNS in response
to viral infection. Indeed, treatment of MHV
infected mice with either anti-IP-10 or anti-
Mig resulted in a significant decrease in the
numbers of CD4+ and CD8+ T lymphocytes
infiltrating into the CNS when compared to
control mice (2,3) (Table 2). Correlating with
the decrease in T lymphocyte infiltration was
a marked decrease in the transcript levels of
CXCR3 present within the CNS of MHV
infected mice treated with either anti-IP-10 or
anti-Mig (2,3) (Figure 2).
One mechanism by which T cells partici-
pate in viral clearance is through the release
of the TH1 cytokine IFN-γ (18,19). Examina-
tion of IFN-γ transcript levels within the CNS
of MHV infected mice revealed that anti-
IP-10 and anti-Mig treated mice displayed a
significant decrease in IFN-γmRNA levels as
compared to levels present in NRS treated con-
trol mice (2,3). Corresponding with the
decrease in IFN-γ transcript levels was a sig-
nificant decrease in IFN-γ protein levels in
anti-IP-10 and anti-Mig treated mice (2,3)
(Fig. 3).
Neutralization of IP-10 and Mig activity
results in increased mortality,delayed viral clear-
ance and inhibition of a protective TH1 response
characterized by infiltrating T lymphocytes and
IFN-γ expression (2,3). Collectively, these data
indicate that both IP-10 and Mig are important
sentinel molecules that help promote a protec-
tive immune response characterized by T lym-
phocyte infiltration and IFN-γ expression
following MHV infection of the CNS.
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Fig. 2. Decreased levels of CXCR3 mRNA transcripts in brains of mice treated with either anti-IP-10 or
anti-Mig. Total RNA was extracted from the brains of MHV infected mice treated with either anti-IP-10,
anti-Mig or NRS at 7 d p.i. and subjected to RT-PCR analysis. Mice treated with either anti-IP-10 or
anti-Mig show a marked decrease in the levels of CXCR3 in the CNS when compared to NRS treated mice.
Top panel: CXCR3; bottom panel: L32 control (Sham, n = 1; anti-IP-10, n = 2; anti-Mig, n = 2; NRS,
n = 2).
Table 2. CNS T lymphocyte infiltration flow cytometric analysis
Treatment Days post infection n CD4 CD8
Sham 7 2 0.32 ± 0.13a 0.45 ± 0.07b
anti-IP-10 7 5 13.1 ± 2.3b1 16.3 ± 2.1b1
anti-Mig 7 5 19.1 ± 1.8b1 18.2 ± 2.6b1
NRS 7 5 16.4 ± 3.9b1 19.8 ± 3.71b
adata presented as mean ± SEM
bp<0.005 when compared to mice treated with NRS.
Chemokines and MHV-Induced
Demyelination
We have recently assessed the contributions
of CD4+ and CD8+ T lymphocytes to demyeli-
nation by infecting either CD4–/– or CD8 –/–
mice with MHV and evaluating the severity
of neurologic disease (1). MHV infection of
CD4–/– and CD8–/– mice resulted in increased
mortality and delayed clearance of virus from
the CNS which is consistent with previous
studies demonstrating an important role for
T lymphocytes in CNS host defense (1,13,
14,28,29). Interestingly, infected CD4–/– mice
displayed a significant decrease in the level of
CNS inflammation as well as demyelination
when compared to both CD8–/– and wild-type
mice (Table 3). Immunophenotyping of the
CNS cellular infiltrate in CD4–/– mice revealed
a significant decrease in the numbers of acti-
vated macrophage/microglia (1). Furthermore,
analysis of chemokines expressed within the
brains of CD4–/–, CD8–/–, and wild-type mice
revealed significantly lower levels of RANTES
mRNA and protein within the CNS of infected
CD4–/– mice as compared to wild-type and
CD8–/– mice. These data suggested that CD4+
T lymphocytes either produced and/or influ-
enced the production of RANTES by other
cellular sources e.g., glial cells and/or lym-
phocytes. Furthermore, RANTES is known to
exert a potent chemotactic effect on macro-
phages suggesting that the decreased demyeli-
nation and inflammation within CD4–/– mice
is, in part, due to diminshed RANTES expres-
sion that results in decreased macrophage infil-
tration into the CNS (30).
To directly characterize the role of RANTES
in contributing to MHV-induced CNS inflam-
mation and demyelination, MHV-infected
mice were treated with goat antisera specific
for RANTES. Consistent with the disease phe-
Liu and Lane116
Fig. 3. Decreased expression of IFN-γ in anti-
IP-10 and anti-Mig treated mice. IFN-γ protein levels
present within the brains of mice at 7 d p.i. were deter-
mined by ELISA. Data are presented as mean ± SEM.
(* p<0.05 when compared to NRS treated mice.)
Table 3. Inflammation and demyelination
Mouse type Days post infection n Inflammationc Demyelinationd
C57BL/6 (WT) 12 3 2.8 ± 0.4a 2.6 ± 0.3a
CD8–/– 12 3 2.5 ± 0.5a 2.6 ± 0.7a
CD4–/– 12 3 1.4 ± 0.3a 1.2 ± 0.2b
anti-RANTES 12 3 1.4 ± 0.6a 1.1 ± 0.3b
ap<0.05 when compared to both wild-type and CD8–/– mice.
bp<0.001 when compared to both wild-type and CD8–/– mice.
c,dData presented on a previously described scale of 0–4, with 4 being most severe (1).
notype observed in CD4–/– mice, treatment of
mice with anti-RANTES resulted in delayed
viral clearance from the CNS, decreased cel-
lular infiltration, and a significant reduction
in the severity of demyelination (Table 3) (1).
The impaired capacity to clear virus from the
brain correlates with the limited infiltration of
CD4+ and CD8+ T lymphocytes into the brain
following anti-RANTES treatment (1).
Summary and Conclusions
Our studies on the functional activity of
chemokines during MHV-induced CNS dis-
ease illustrate the complexity of chemokine
expression as it relates to both host defense
and disease development. Early expression of
the T lymphocyte chemoattractant chemokines
IP-10 and Mig represents a dominant response
to MHV infection of the brain and is impor-
tant in attracting IFN-γ producing T lympho-
cytes (both CD4+ and CD8+ subsets) into the
CNS which then participate in viral clearance.
Further, RANTES expression also contributes
to host defense by exerting a chemotactic effect
upon T lymphocytes and macrophages. How-
ever, MHV RNA and antigen persists within
white matter tracts of the CNS and animals
develop a demyelinating disease in which
T lymphocytes and macrophages are impor-
tant contributors. Chronic expression of the
chemokines IP-10 and RANTES are detected
within areas of MHV persistence undergoing
demyelination suggesting that these molecules
participate in the disease process by main-
taining a chronic inflammatory response.
Indeed, anti-RANTES treatment of persis-
tently infected mice resulted in diminished
macrophage infiltration into white matter tracts
accompanied by a decrease in the severity of
demyelination. In addition, we have recently
determined that anti-IP-10 (but not anti-Mig)
treatment of MHV infected mice with estab-
lished demyelinaton resulted in decreased
T lymphocyte infiltration into the CNS,
decreased demyelination, and increased
remyelination to damaged axons (M.T.L. and
T.E.L., unpublished observations). With
regards to chronic expression of chemokines
and immune-mediated demyelination, a sim-
ilar situation exists in MS patients. Recent
studies have clearly demonstrated increased
expression of chemokines and chemokine
receptors within the cerebral spinal fluid of
MS patients undergoing acute clinical attack
as well as within demyelinating lesions sug-
gesting a pathogenic role for these molecules
by attracting leukocytes into the CNS (31–33).
IP-10, Mig, and RANTES are among the
chemokines expressed in MS patients and
are associated with demyelinating lesions
(31–33). Therefore, it is interesting to specu-
late that these chemokines function to attract
T lymphocytes and macrophages into the CNS
which ultimately results in white matter
destruction. Finally, it is important to note that
our studies on antibody-mediated neutraliza-
tion of chemokine activity as a means to mod-
ulate the severity of neuroinflammation and
neurologic disease supports and extends ear-
lier studies that have suggested that targeting
chemokines may offer novel methods for inter-
ventional therapies aimed at treating human
neuroinflammatory diseases such as MS
(34,35).
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